Literature DB >> 8855288

Covalent HLA-B27/peptide complex induced by specific recognition of an aziridine mimic of arginine.

G A Weiss1, R J Valentekovich, E J Collins, D N Garboczi, W S Lane, S L Schreiber, D C Wiley.   

Abstract

The class I major histocompatibility complex (MHC) glycoprotein HLA-B27 binds short peptides containing arginine at peptide position 2 (P2). The HLA-B27/peptide complex is recognized by T cells both as part of the development of the repertoire of T cells in the cellular immune system and during activation of cytotoxic T cells. Based on the three-dimensional structure of HLA-B27, we have synthesized a ligand with an aziridine-containing side chain designed to mimic arginine and to bind covalently in the arginine-specific P2 pocket of HLA-B27. Using tryptic digestion followed by mass spectrometry and amino acid sequencing, the aziridine-containing ligand is shown to alkylate specifically cysteine 67 of HLA-B27. Neither free cysteine in solution nor an exposed cysteine on a class II MHC molecule can be alkylated, showing that specific recognition between the anchor side-chain pocket of an MHC class I protein and the designed ligand (propinquity) is necessary to induce the selective covalent reaction with the MHC class I molecule.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8855288      PMCID: PMC38263          DOI: 10.1073/pnas.93.20.10945

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  The human class II MHC protein HLA-DR1 assembles as empty alpha beta heterodimers in the absence of antigenic peptide.

Authors:  L J Stern; D C Wiley
Journal:  Cell       Date:  1992-02-07       Impact factor: 41.582

2.  Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry.

Authors:  D F Hunt; R A Henderson; J Shabanowitz; K Sakaguchi; H Michel; N Sevilir; A L Cox; E Appella; V H Engelhard
Journal:  Science       Date:  1992-03-06       Impact factor: 47.728

3.  Crystallization and preliminary X-ray diffraction studies of the human major histocompatibility antigen HLA-B27.

Authors:  J C Gorga; D R Madden; J K Prendergast; D C Wiley; J L Strominger
Journal:  Proteins       Date:  1992-01

4.  Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes.

Authors:  S D Sharma; B Nag; X M Su; D Green; E Spack; B R Clark; S Sriram
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

5.  Identification of self peptides bound to purified HLA-B27.

Authors:  T S Jardetzky; W S Lane; R A Robinson; D R Madden; D C Wiley
Journal:  Nature       Date:  1991-09-26       Impact factor: 49.962

6.  High association of an HL-A antigen, W27, with ankylosing spondylitis.

Authors:  L Schlosstein; P I Terasaki; R Bluestone; C M Pearson
Journal:  N Engl J Med       Date:  1973-04-05       Impact factor: 91.245

7.  Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders.

Authors:  R E Hammer; S D Maika; J A Richardson; J P Tang; J D Taurog
Journal:  Cell       Date:  1990-11-30       Impact factor: 41.582

8.  Complete amino acid sequence of the FK506 and rapamycin binding protein, FKBP, isolated from calf thymus.

Authors:  W S Lane; A Galat; M W Harding; S L Schreiber
Journal:  J Protein Chem       Date:  1991-04

9.  The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation.

Authors:  D R Madden; J C Gorga; J L Strominger; D C Wiley
Journal:  Nature       Date:  1991-09-26       Impact factor: 49.962

10.  Cells expressing a major histocompatibility complex class I molecule with a single covalently bound peptide are highly immunogenic.

Authors:  E Mottez; P Langlade-Demoyen; H Gournier; F Martinon; J Maryanski; P Kourilsky; J P Abastado
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

View more
  1 in total

1.  Synthesis of (2S)-2-amino-7,8-epoxyoctanoic acid and structure of its metal-bridging complex with human arginase I.

Authors:  Tatiana Y Zakharian; Luigi Di Costanzo; David W Christianson
Journal:  Org Biomol Chem       Date:  2008-08-06       Impact factor: 3.876

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.